Difference in Central and Peripheral Total Tryptase Concentration/Level in Fatal Anaphylaxis: A Case Report

Area of Science:

• Forensic Pathology
• Toxicology
• Immunology

Background:

• Postmortem tryptase is a key biomarker for diagnosing fatal anaphylaxis.
• Previous studies indicate variations in postmortem tryptase levels between central and peripheral blood in the general population.
• The variation of these levels in fatal anaphylaxis cases remains under-investigated.

Purpose of the Study:

• To investigate whether postmortem total tryptase concentrations vary between central and peripheral blood samples in a fatal anaphylaxis case.
• To provide evidence for or against significant differences in tryptase levels based on blood sample origin in anaphylactic deaths.

Main Methods:

• A case of radiocontrast-induced anaphylaxis resulting in death was analyzed.
• Postmortem total tryptase concentrations were measured in central blood samples (aorta, inferior vena cava).
• Postmortem total tryptase concentrations were measured in peripheral blood samples (femoral artery, femoral vein).

Main Results:

• Central blood samples (arterial and venous) showed postmortem total tryptase levels greater than 200 μg/L.
• Peripheral blood samples (arterial and venous) showed postmortem total tryptase levels around 110 μg/L.
• A significant difference in postmortem total tryptase concentrations was observed between central and peripheral blood samples.

Conclusions:

• This case report demonstrates that postmortem total tryptase concentrations vary between central and peripheral blood samples in fatal anaphylaxis.
• The findings suggest that the site of blood collection is a critical factor in interpreting postmortem tryptase levels for diagnosing anaphylaxis.
• Further research is warranted to establish standardized guidelines for sample collection and interpretation in postmortem tryptase analysis.